logo
Health care advocates to hold town hall forum aimed at keeping Regional Hospital of Scranton open

Health care advocates to hold town hall forum aimed at keeping Regional Hospital of Scranton open

Yahoo04-03-2025

The SEIU Healthcare workers' union and other advocates will hold a town hall forum next week focused on sparing Regional Hospital of Scranton from possible closure.
Ads published recently in The Times-Tribune promoting a 'Save Regional Hospital' town hall March 13 at 4 p.m. at Hilton Scranton & Conference Center, 100 Adams Ave., in Scranton, say SEIU hospital employees, patients and residents of the Scranton area are 'united in our commitment to save Regional Hospital.' The ads contain over 1,400 names and an 'open letter to our elected officials' that addresses the uncertainty the institution faces, saying, 'We must save Regional Hospital for this and future generations of Scranton area families.'
Those who will attend the the town hall are asked to sign up online at saveregionalhospital.org. Doors will open at 3:30 p.m. and the event will be held in the Electric City Ballroom.
It's the latest development regarding financial difficulties of the for-profit Commonwealth Health system, which is Regional's parent firm, that have clouded the future of both Regional Hospital and its nearby sister campus, Moses Taylor Hospital. Regional and Moses Taylor are separate facilities but operate under a single license following a 2022 merger with operations coordinated across the two campuses — such that Regional's fate determines Moses Taylor's fate.
Last summer, a nonprofit called WoodBridge Healthcare announced plans to purchase Commonwealth Health's financially struggling hospitals from subsidiaries of Tennessee-based Community Health Systems Inc., which is Commonwealth's corporate parent. That plan fueled cautious optimism among health care workers, patients and local elected officials. But its collapse in late November renewed concerns that Regional and Moses Taylor could close if not acquired by another buyer.
Workers and other stakeholders voiced such concerns at a packed town hall forum in December, when officials revealed that other health care providers had expressed interest in the Commonwealth facilities. At that town hall, state Rep. Bridget Kosierowski, D-114, Waverly Twp., expressed confidence that a new deal would arise to spare Regional, and possibly by the end of that year.
State Rep. Bridget Kosierowski speaks the Electric City Ballroom of the Hilton Scranton and Conference Center in Scranton Monday, Dec. 16, 2024. (SEAN MCKEAG / STAFF PHOTOGRAPHER)
That did not come to pass. In January, Kosierowski, a longtime nurse and leader on the issue of health care access locally, said discussions were still ongoing and had the attention of Gov. Josh Shapiro; and she remained confident that Regional ultimately would be saved.
In a phone interview Monday, Kosierowski said she looked forward to attending the upcoming town hall meeting and again said she believes Regional Hospital will survive. Several nonprofit entities have come forward as potential buyers and have received facilities' assessments that they are reviewing, she said. These entities all continue to discuss a potential acquisition and transitioning away from Commonwealth Health, she said, noting she could not be more specific. But she expects that one of the suitors could soon emerge from the group as the successful buyer.
'I'm anticipating an announcement very soon,' Kosierowski said. 'I can say with certainty we're not closing. This institution is not closing. Everyone is still at the table.'
The ad for the upcoming town hall said, 'The collapse of the proposed sale of Regional Hospital to WoodBridge Healthcare left many in our community worrying about what will happen to the hospital, but we must press forward and secure a future for this essential institution.'
Other details in the ad included that Regional:
• Delivers 70% of the babies in Lackawanna County.
• Cares for 36,000 patients in the emergency department each year.
• Is the only hospital in the county with a level 3 neonatal intensive care unit and a geriatric behavioral health unit.
• Employs over 1,000 people and contributes nearly $150 million a year in local wages and family benefits. 'The loss of these jobs would be devastating to the families of Regional employees and to our local economy. Other local hospitals cannot absorb the number of workers who would be displaced,' the ad says.
It also says that other local hospitals already have emergency department wait times above the national average and simply do not have the capacity to take on all of Regional's patients. A closure of Regional would mean 'a severe reduction' in access to care and a dangerous increase in travel time for patients seeking critical or lifesaving care.
Kosierowski also said a closure of Regional would be catastrophic for the local health care landscape.
'As a nurse I tend not to be an alarmist, but people will die — babies and mothers are going to lose their lives if we do not keep these doors open,' Kosierowski said.
Meanwhile, Kosierowski also will host an unrelated public forum titled 'Hands Off Our Healthcare: A Town Hall on Medicare & Medicaid Cuts,' on Monday from 6-8 p.m. at the Peoples Security Bank Theater at Lackawanna College, 501 Vine St. in Scranton.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

UnitedHealth Group received multiple bids for Latin American operations
UnitedHealth Group received multiple bids for Latin American operations

Yahoo

time43 minutes ago

  • Yahoo

UnitedHealth Group received multiple bids for Latin American operations

-- UnitedHealth Group (NYSE:UNH) is considering several offers for its Latin American operations, according to a Reuters report on Monday. The move comes as the largest U.S. health insurer faces challenges that include the departure of its CEO and an alleged criminal accounting investigation. The insurer has been attempting to leave Latin America since 2022, with the sale of its Banmedica subsidiary becoming more urgent in recent months due to increasing pressures on multiple fronts, the report said. So far, UnitedHealth has reportedly received four preliminary bids for Banmedica, which operates in Colombia and Chile, with an estimated value of about $1 billion. In May, UnitedHealth's shares dropped 25.5%, and the year-to-date decline stands at 40%. The company withdrew from Brazil in 2023 and from Peru in March 2025. It aims to secure around $1 billion for Banmedica's operations in Colombia and Chile. The company anticipates setting a deadline for final proposals as early as July. The bids reportedly include offers from Washington, D.C.-based private equity firm Acon Investments, Sao Paulo-based private equity firm Patria Investments, Texas non-profit health organization Christus Health, and Lima-based healthcare and insurance provider Auna. The report mentioned that Auna is currently in discussions with a financial partner. Related articles UnitedHealth Group received multiple bids for Latin American operations Tesla shares slip after double downgrade amid Trump feud fallout What are the three big things in markets now? RBC weighs in

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program
RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

Yahoo

timean hour ago

  • Yahoo

RenaissThera Achieves Discovery Milestone in Its Oral Obesity Drug Program

BENGALURU, India, June 09, 2025 (GLOBE NEWSWIRE) -- RenaissThera Private Limited ('RenaissThera'), a Bengaluru-based biotechnology company, announced a major milestone in its obesity drug discovery program targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR). GIPR, an incretin receptor, is a validated target for peptide-based parenteral therapies where both stimulation and inhibition has shown efficacy in treating obesity and its co-morbidities. RenaissThera is developing novel, oral small molecules, both agonists and antagonists, as a more affordable and convenient alternative aiming to expand access for underserved populations in the global obesity market projected to reach USD 38 billion by 2032. Oral small molecules are more economical to manufacture and distribute than peptide-based obesity drugs. These molecules were designed and screened using proprietary AI and ML based platforms, followed by demonstrating in-vitro activity in cell lines and in-vivo activity to impact GIPR in mice to yield 'Hits'. RenaissThera now is advancing these Hits to the Lead optimization program to select candidates for pre-IND studies. RenaissThera is filing 'Composition of Matter' and utility patents for these oral novel small molecule GIPR modulators and continues to expand its innovation portfolio targeting GIP, GLP-1, and apelin receptors in obesity and diabetes. Its AI-powered Innovation Platform, integrating GenAI and machine learning tools, is accelerating the design and optimization of novel small molecules. 'We are grateful to our investors and collaborators for supporting us in reaching this milestone. Our team is focused on pushing candidates toward IND-readiness next year and we are in active discussions with potential pharma partners and investors interested in our obesity program,' said Meena, MD, CEO of RenaissThera. RenaissThera's progress was enabled through its collaboration with VedTechBio Research Private Limited which enabled access to its Agentic AI platform RxAgentAI and discovery expertise. 'We are very pleased with the outcomes of our collaboration with RenaissThera. This milestone further validates our platform and capabilities across key therapeutic areas including obesity, Type 2 diabetes, oncology, and inflammation,' said VedTechBio's Managing Director Sudhir Nagarajan. About RenaissThera RenaissThera is a Bengaluru-based biotech company developing affordable, AI-powered novel small-molecule therapies for high-unmet-need diseases like obesity and diabetes. Its goal is to innovate for underserved populations and expand global access to novel therapies. It leverages India's CRO ecosystem for early-stage R&D to deliver globally relevant innovation. For more information Please contact: Media: Lakshmi Ramakrishna lramakrishna@ Investor & Partnership: Ramkesh Meena bd@

UMMC expands health care access with UMMC Madison
UMMC expands health care access with UMMC Madison

Yahoo

time2 hours ago

  • Yahoo

UMMC expands health care access with UMMC Madison

CANTON, Miss. (WJTV) – The University of Mississippi Medical Center (UMMC) acquired Merit Health Madison, which now operates as UMMC Madison. With 67 licensed beds, officials said the Canton-based hospital will expand UMMC's mission to deliver high-quality, accessible care to more Mississippians while providing additional training opportunities for future health care providers. Lyme-disease isn't the only tick-borne threat. Doctors warn these other diseases are spreading 'As Mississippi's only academic medical center, we must continue to be focused on our three-part mission to educate the next generation of health care providers, conduct impactful research and deliver accessible high-quality health care,' said Dr. LouAnn Woodward, vice chancellor of health affairs. 'Every decision we make is rooted in our mission.' The acquisition was finalized May 1. As the full owner, UMMC will integrate the facility more closely into its academic and health care system. UMMC Madison will continue to provide a wide range of community hospital services, including emergency services, medical-surgical care, ICU, pulmonology, pathology, cardiology, radiology, neurology, nephrology, general surgery and GI services. The hospital will operate as a community hospital. UMMC Madison will also become a training site for medical students, residents and fellows, who will have the opportunity to learn at a community hospital. Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store